is a doctor in pharmacology and toxicology and has been heading the pharmaceutical market department at the IGES Institute since 2011, where she has worked since 2001. The focus of her scientific work is on analyzes of the development of the pharmaceutical market, including forecasts, pharmacoepidemiological studies, health services research studies and topics relating to the benefit assessment of new drugs, which also includes the creation of benefit dossiers.